Findings suggest subchronic Pb inhalation changes platelet responsiveness and fibrin clot structure, consistent with a prothrombotic phenotype, should not be interpreted as proof that Pb caused an in vivo thrombosis event.
Abstract
Lead (Pb) remains one of the major environmental contaminants and affects multiple systems. Nevertheless, the impact of inhaled Pb exposure on the hemostatic system remains poorly understood. In this research, we evaluated the effects of subchronic lead inhalation on platelet count and activity, D-dimer levels, and clot structure in a murine model. Forty male CD-1 mice were exposed to nebulized particles of lead acetate (5μg/m3) or vehicle (saline solution 0.9%) twice weekly for 8 weeks. We measured platelet count using an automated counter, ADP-induced platelet aggregation using optical methods, plasma D-dimer levels by ELISA, and clot ultrastructure by scanning electron microscopy, and analyzed these at different time points (2, 4, 6, and 8 weeks). Femur Pb concentrations were measured at 8 weeks as evidence for Pb absorption and accumulation. Platelet counts were similar between the study groups. However, Pb exposure generated a biphasic platelet response: decreased function in weeks 2 and 4, followed by increased aggregation in weeks 6 and 8. In Pb-exposed mice, plasma D-dimer levels were significantly elevated compared with controls at weeks 6 and 8. Ultrastructural analysis showed a more compact fibrin mesh with thinner fibers and less space between them. These findings suggest subchronic Pb inhalation changes platelet responsiveness and fibrin clot structure, consistent with a prothrombotic phenotype. Since thrombosis, thrombin generation, and fibrinolytic resistance were not directly measured, these results should not be interpreted as proof that Pb caused an in vivo thrombosis event.
Pathological platelet activation drives thrombosis and is a major contributor to morbidity and mortality. Current antiplatelet therapies reduce thrombotic risk but target a limited range of signaling pathways, have minimal impact on established platelet aggregates, and are frequently associated with bleeding complicati...
J. Buchholz, Maria Shoykhet, Anthea C. Darius et al.· Frontiers in Immunology· 0 citations
Background Atherothrombosis is a chronic, multifactorial, and progressive disease responsible for a significant number of deaths globally. It involves interactions between endothelial dysfunction, coagulation activation, platelet activity, and fibrin turnover. Combined oral contraceptives (COCs) may influence these pat...
O. Fabunmi, Fayokemi C. Fabunmi, A. O. Olaiya et al.· Current Research in Physiolo...· 0 citations
TAVR induces a coordinated thromboinflammatory response across systemic, cellular, and transcriptomic levels, characterized by systemic coagulation and inflammatory activation, platelet phenotypic alterations, and transcriptional enrichment of platelet activation pathways.
D. Hesselbarth, A. Hoelzle, S. Teegelbekkers et al.· European Heart Journal· 0 citations
Gastrointestinal injury remains a major limitation of aspirin-based antiplatelet therapy. Sofalcone is a clinically used mucoprotective drug with an established safety profile, but its effects on platelet function remain unclear. This study aims to evaluate the antiplatelet effects of sofalcone and elucidate its underl...
Meng-Chun Tsai, K. Hsieh, Ju-Ying Tsai et al.· European Journal of Pharmaco...· 0 citations
Organotin compounds, such as tributyltin (TBT), are environmental contaminants known for toxic effects. Subacute exposure to TBT leads to vascular dysfunction associated with increased production of reactive oxygen species (ROS). This study aimed to investigate whether a single exposure to TBT induces endothelial dysfu...
V. Marques, Gersica de Almeida Correia Santos, K. Silva et al.· Toxicology Letters· 0 citations